## Abstract ## Objective To evaluate the efficacy and safety of alefacept in combination with methotrexate (MTX) for the treatment of psoriatic arthritis (PsA). ## Methods Patients were eligible for this randomized, doubleβblind, placeboβcontrolled trial if they were ages 18β70 years and had act
A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: Results of the METGO study
β Scribed by Allen J. Lehman; John M. Esdaile; Alice V. Klinkhoff; Eric Grant; Avril Fitzgerald; Janice Canvin; The METGO Study Group
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 103 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To investigate the relationship between serum concentrations of infliximab, a monoclonal antiβtumor necrosis factor Ξ± antibody, and clinical improvement from infliximab therapy for rheumatoid arthritis (RA). ## Methods Multiple blood samples were obtained from each of 42
## Abstract ## Objective To evaluate the safety, efficacy, and pharmacokinetics of 50 mg etanercept administered subcutaneously once weekly in adult patients with active rheumatoid arthritis (RA). ## Methods Four hundred twenty RA patients were randomized to receive, in a blinded manner, the stu